Cite
MLA Citation
A.F. Sobrero et al.. “2118 Quality of life (QoL) during second-line treatment with FOLFIRI +/- panitumumab (pmab) in patients (pts) with RAS wild-type (WT) metastatic colorectal carcinoma (mCRC).” European journal of cancer, vol. 51, n.d., pp. S369–S370. http://access.bl.uk/ark:/81055/vdc_100030628213.0x000031